CIK 0001427925
- Non-accelerated filer
- Smaller reporting company
TALPHERA, INC.
Sign in to watch- Ticker
- TLPH
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 412193603
- Phone
- +1 650-216-3500
- Business address
- 1850 GATEWAY DRIVE, SUITE 175, SAN MATEO, CA, 94404
- Former names
- ACELRX PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-06-17 | ADAMS ADRIAN Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2021-06-17 | Rosen Howard B Director | Grant or award | +10,000 | 78,750 | ||
| 2021-06-17 | Rosen Howard B Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2021-06-17 | Afable Richard Director | Grant or award | +10,000 | 22,250 | ||
| 2021-06-17 | Afable Richard Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2021-06-17 | Bozilenko Marina Director | Grant or award | +10,000 | 25,000 | ||
| 2021-06-17 | Bozilenko Marina Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2021-06-17 | HOFFMAN STEPHEN J Director | Grant or award | +10,000 | 21,250 | ||
| 2021-06-17 | HOFFMAN STEPHEN J Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2021-06-17 | EDWARDS MARK G Director | Grant or award | +10,000 | 261,250 | ||
| 2021-06-17 | EDWARDS MARK G Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2021-03-30 | Bozilenko Marina Director | Grant or award | +15,000 | 15,000 | ||
| 2021-03-30 | Bozilenko Marina Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2021-03-03 | Palmer Pamela P Chief Medical Officer | Grant or award | +68,750 | 666,621 | ||
| 2021-03-03 | Palmer Pamela P Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +137,500 | 137,500 | ||
| 2021-03-03 | Palmer Pamela P Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +68,750 | 68,750 | ||
| 2021-03-03 | Dasu Badri N Chief Engineering Officer | Grant or award | +50,000 | 204,757 | ||
| 2021-03-03 | Dasu Badri N Chief Engineering Officer | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2021-03-03 | Dasu Badri N Chief Engineering Officer | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2021-03-03 | ASADORIAN RAFFI Chief Financial Officer | Grant or award | +68,750 | 260,597 |
Page 11 of 17 · 329 trades